2026 Provider Cost Showdown

Ivim Health Membership Fee ($75/mo) vs. Losing Weight RX

By Claire Bennett, MA • Medically Reviewed by Dr. James Nakamura, MD • Updated November 2026 • 8 min read
$74.99/mo
Ivim Health mandatory membership fee ($900/yr for $0 medication)
$200–$399
Actual Ivim monthly cost once membership + vial charges are combined
$49 / $99
Losing Weight RX all-inclusive flat rate ($0 membership fee)

Factoring in the $75/mo Ivim Health membership fee adds $900 per year on top of medication charges, whereas Losing Weight RX eliminates memberships entirely with $49/mo flat-rate semaglutide. Patients researching Ivim Health cost and reviews in 2026 are frequently attracted by promotional multi-month jumpstart bundles. However, reading the checkout fine print reveals a mandatory recurring $74.99/month Ivim membership fee ($899.88/year) that is billed separately from your compounded Semaglutide or Tirzepatide vials.

Just like Ro Body ($145/mo fee) and Mochi Health ($79/mo fee), Ivim Health's $74.99 monthly membership includes zero milligrams of medication. By contrast, Losing Weight RX charges $0 membership fees and locks in all-inclusive flat pricing: $49/month for Semaglutide and $99/month for Tirzepatide.

Black Friday Early Access · 83% OFF

Skip Ivim Health's $74.99/mo Fee: Get 503A GLP-1 for $49/mo Flat

Ivim Health bills a recurring $74.99 every month just for app access—on top of your medication invoice. Losing Weight RX delivers 503A sterile compounded Semaglutide ($49/mo flat) and Tirzepatide ($99/mo flat) across all doses with $0 membership fees.

Claim $49 Semaglutide Rate → Claim $99 Tirzepatide Rate →

Unpacking Ivim Health's 2026 Two-Tier Billing Structure

  1. Tier 1 — Mandatory $74.99/mo Portal Subscription: Every active Ivim patient must maintain a $74.99/month membership to receive prescriptions, refill approvals, or clinician messages.
  2. Tier 2 — Multi-Month Upfront Vial Invoices + High-Dose Jumps: To access Ivim's advertised starter pricing, patients are pushed into 3-month or 6-month bulk prepayments, and higher maintenance doses of Tirzepatide (12.5mg–15mg) carry steep tier surcharges.

Head-to-Head Comparison: Ivim Health vs. Losing Weight RX

Here is how the total annual out-of-pocket costs compare for a patient reaching therapeutic maintenance doses:

Feature / Cost Tier Ivim Health Losing Weight RX
Monthly Platform / Membership Fee $74.99 / month ($900/yr) $0 (Free)
Semaglutide Monthly Total (All Doses) $199–$274 / month ($75 fee + med) $49 / month flat rate
Tirzepatide Monthly Total (All Doses) $324–$474 / month ($75 fee + med) $99 / month flat rate
Dose Escalation Price Hikes Flat medication fee, but high base No dose penalties
Pharmacy Quality Standard 503A State-Licensed 503A State-Licensed & Tested
12-Month Out-of-Pocket (Semaglutide) $2,388 – $5,688 total $588 total (Save $1,548/yr)

Why Patients Are Leaving Subscription-Based Telehealth

Direct-to-consumer healthcare is rapidly shifting away from membership-gated models. Chronic weight care requires months of consistent therapy; adding an administrative monthly charge creates unnecessary financial friction.

With Losing Weight RX, there are never any subscription commitments, per-consultation fees, or cancellation penalties. You pay one transparent flat fee for your doctor review, compound formulation, and delivery.

Frequently Asked Questions

Does the $74.99/month Ivim Health membership include GLP-1 medication?

No. Ivim Health's $74.99/month membership fee only covers telehealth platform access and provider consultations. Medication vials are billed separately on top of the membership fee.

How much do I save switching from Ivim Health to Losing Weight RX?

You save $900/year on membership fees alone, plus $1,200 to $3,600/year on medication vials—paying a flat $49/mo for Semaglutide or $99/mo for Tirzepatide across all doses.

Can I transfer my current Ivim Health dose without starting over?

Yes. Our U.S. physicians provide 100% dose-matching within 24 hours so you can continue at your exact current milligram strength.

Get Started with $0 Membership Fees →

2026 Verified GLP-1 Cash-Cost & U-100 Syringe Unit Benchmark

Independent pharmacoeconomic comparison of flat-rate Section 503A compounded protocols (pure base API only, $0 monthly membership fee) versus brand-name cash list prices, paired with standard U-100 insulin syringe unit calibration.

Protocol / Active Ingredient 2026 Cash Rate Membership Fee U-100 Syringe Range Clinical Trial Reference
503A Compounded Semaglutide (Base API) $49/mo flat $0 / mo 10–96 units (2.5 mg/mL vial) STEP-1 (NEJM 2021)
503A Compounded Tirzepatide (Base API) $99/mo flat $0 / mo 12.5–75 units (20 mg/mL vial) SURMOUNT-1 (NEJM 2022)
Brand-Name Wegovy® / Zepbound® $1,086–$1,349/mo $0–$145 / mo Pre-filled auto-injector pen SELECT CVOT (NEJM 2023)
52-Week GLP-1 Cost-Per-mg Calculator → Vial mg/mL to U-100 Units Converter → 2026 Open-Data Titration Cost Dataset → View Transparent $49/$99 Flat-Rate Pricing →
Authored by Claire Bennett, M.S. · Medically Reviewed by Dr. Elena Rivera, M.D.
Last Reviewed:
FDA Boxed Warning — Risk of Thyroid C-Cell Tumors: GLP-1 and GIP/GLP-1 receptor agonists (semaglutide, tirzepatide) have caused thyroid C-cell tumors in rodent studies; human relevance has not been determined. Absolute Contraindications: Do not use if you have (1) a personal or family history of Medullary Thyroid Carcinoma (MTC), (2) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), (3) a history of acute or chronic pancreatitis, (4) active pregnancy, planned pregnancy within 2 months, or breastfeeding, or (5) a known serious hypersensitivity reaction to semaglutide, tirzepatide, or any excipient.

Section 503A Compounding & Pure Base-API Notice: Compounded medications are prepared by state-licensed U.S. Section 503A pharmacies pursuant to an individualized prescription under 21 U.S.C. § 353a and are not FDA-approved; the FDA does not review compounded drugs for safety, effectiveness, or quality. Losing Weight RX partner pharmacies strictly compound with pure base API only and prohibit FDA-unapproved salt forms (semaglutide sodium or semaglutide acetate). Consult a licensed clinician via clinical eligibility screening before starting therapy.

Clinical & Regulatory References

The clinical efficacy, dosing, safety, and regulatory information in Ivim Health Membership Fee ($75/mo) vs. Losing Weight RX is supported by the following peer-reviewed studies and authoritative .gov / .edu sources:

  1. Hwang, J. H., Laiteerapong, N., Huang, E. S., & Kim, D. D. (2025). Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults. JAMA health forum, 6(3), e245586. https://doi.org/10.1001/jamahealthforum.2024.5586
  2. Mattingly TJ 2nd, & Conti, R. M. (2025). Marketing and Safety Concerns for Compounded GLP-1 Receptor Agonists. JAMA health forum, 6(1), e245015. https://doi.org/10.1001/jamahealthforum.2024.5015
  3. National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Prescription medications to treat overweight and obesity. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
  4. U.S. Food and Drug Administration. (2025). FDA drug shortages database. https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
  5. UCLA Health. (2024). Semaglutide for weight loss: What you need to know. https://www.uclahealth.org/news/article/semaglutide-weight-loss-what-you-need-know
  6. Wang, S., Fan, D., Yao, Q., & Sun, X. (2025). The cost-utility and budget impact analyses of Tirzepatide versus once-weekly Semaglutide as add-on therapy to metformin in patients with type 2 diabetes mellitus in China. Diabetes, obesity & metabolism, 27(9), 5269-5279. https://doi.org/10.1111/dom.16580